Full text

Turn on search term navigation

1. Introduction

Seminal ejaculate is composed of secretions from testis (5%) and other accessory sex glands, such as seminal vesicles (50–65%), prostate (20–30%), and bulbourethral glands (<5%) [1,2]. The main cellular portion of the semen is composed by spermatozoa. However, semen also contains non-sperm cells known as round cells, either of spermatogenic or non-spermatogenic origin [3]. Spermatogenic round cells include immature germ cells and degenerated spermatids, whereas non-spermatogenic round cells include exfoliating epithelial cells form prostate and seminal vesicles and inflammatory cells, such as leukocytes, lymphocytes, and macrophages [4,5]. Basic semen analysis is performed on neat semen samples and includes the estimation of round cell concentrations. When round cells are present in excessive amounts (≥1 × 106/mL), the Endtz test or peroxidase staining test is used to detect the leukocyte population [6,7].

The presence of leukocytes ≥ 1 × 106/mL is an indication of genital tract infection or inflammation [8]. The level of seminal leukocytes are elevated in recurrent cigarette smoking and alcohol consuming men [9,10]. These seminal leukocytes are high producers of reactive oxygen species (ROS), which are harmful for spermatozoa when present in excessive amounts, as they induce oxidative stress. ROS can cause nuclear and mitochondrial DNA damages, thus significantly affect sperm function and motility [11]. To minimize the ROS levels, semen samples can be subjected to density gradient centrifugation to remove the seminal leukocytes [12,13,14].

In the era of omics, sperm proteins constitute a great source for understanding the molecular mechanisms of sperm function. Mass spectrometry is a commonly used technique for quantitative proteomic studies [15]. It provides the basis for understanding the biological pathways regulating the normal physiological function of spermatozoa. Sperm proteomic analysis starts with the isolation and separation of sperm cells from seminal plasma. For proteomic experiments, semen samples are frequently stored at −80 °C. However, while freezing the neat semen samples, spermatozoa are stored along with round cells and debris. When the frozen samples are thawed, the round cells present in semen burst. Hence, the extracted total protein will contain a mixture of both sperm and round cell proteins [16]. Gradient centrifugation techniques are widely used to process the semen samples to obtain a pure population of spermatozoa. To date, some studies have used only pure cultures of sperm (without round cells) for global proteomic analysis [17,18,19,20,21], whereas others have used neat semen samples [20,22,23,24]. Thus, it is still unclear (1) whether the processing of semen samples have any interference in the sperm protein expression, and (2) what the contribution is of non-spermatogenic proteins in the evaluation of sperm proteomic profile. The objective of this study was to evaluate the impact of purification (by density gradient) on the sperm proteome detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS) technique.

2. Results 2.1. Semen Parameters

Sperm concentration (81.88 ± 45.51 × 106/mL) and motility (69.79 ± 10.02%) were within normal reference ranges defined by the 2010 WHO guidelines [25]. In the samples used for proteomic analysis, the average leukocyte concentration in leukocytospermic samples (n = 5) was 1.30 ± 0.57 × 106/mL, while the average round cell concentration for samples (n = 5) with round cells < 1 × 106/mL was 0.50 ± 0.26 × 106/mL ( Supplementary Table S1).

2.2. Proteomic Profile of Spermatozoa in Different Groups

LC-MS/MS analysis of pooled samples from group 1, 2, 3, and 4 resulted in a total of 1638, 1393, 1755, and 1404 proteins, respectively. A total of 1486 proteins were identified in control group (leukocyte pure culture). Variation in the total number of proteins identified for triplicate runs were 2.01%, 4.01%, 1.74%, and 9.37% in group 1, 2, 3, and 4, respectively (Figure 1a,b, Supplementary Table S2). Comparative analysis of sperm proteins in group 1 vs. 3 (neat semen) revealed a total of 26 (1.18%) DEPs. Among them, 16 DEPs were overexpressed and 10 DEPs were underexpressed in group 3 (Figure 1a). When comparing group 2 vs. 4 (65% gradient processed semen), only six (0.31%) DEPs were identified (Figure 1b). In group 4, four proteins were underexpressed (AKAP3: A-kinase anchor protein 3, CLPTM1: cleft lip and palate transmembrane protein 1, SLC25A15: mitochondrial ornithine transporter 1, and FAM210A: protein FAM210A), the mitochondrial protein cytochrome c oxidase subunit 6A1 was overexpressed, and monocarboxylate transporter 10 (SLC16A10) was uniquely expressed in group 2. The DEPs differed in their abundance in all the four different groups (Table 1 and Table 2). Lists of all the proteins detected in group 1, 2, 3, and 4 and control group are provided in Supplementary Table S3.

2.3. Comparative Analysis of Human Sperm Protein and Leukocyte Protein

Proteomic profile of group 1, group 3, and control group revealed only 11 DEPs were identified in all three groups. Key proteins associated with sperm function (IZUMO1, PSMD3) were absent and ATP1A1 was underexpressed in control group (Table 3).

2.4. Molecular Pathways Regulated by DEPs in Spermatozoa

Networks generated for DEPs between group 1 and 3 using IPA software revealed that 15 proteins were involved in the cell death and survival, cellular compromise, cellular function, and maintenance pathways (Figure 2a). Whereas aberrant expression of 10 proteins was associated with processes such as cellular assembly and organization, cell signaling, and molecular transport in the spermatozoa (Figure 2b). Functional network analysis also identified Izumo sperm-egg fusion protein 1 (IZUMO1) as a key molecule regulating the cellular assembly and organization, embryonic development, and organismal development pathways (Figure 2c).

3. Discussion

Cellular and molecular functions of a cell are regulated by proteins. In proteomics, selection of a suitable sample, protein extraction technique, and contaminant removal methods are very critical. Transcriptionally and translationally silent spermatozoa depend on the proteins and their post-translational modifications in order to carry out their normal physiological functions to ultimately fertilize the oocyte [26,27]. Therefore, accurate identification and quantification of proteins in mature and immature spermatozoa provides insight into the function of each protein. Concentration of proteins varies from sample to sample, depending on the yield of the spermatozoa and other cells co-existing with sperm cells. In semen, spermatozoa are present along with other non-sperm cells, especially round cells of spermatogenic and non-spermatogenic origin [3,4,5]. In general, prior to the use of semen samples in proteomic experiments, they are stored as whole ejaculate at −80 °C. However, it remains to be elucidated what the contribution is of the non-spermatogenic proteins to the evaluation of sperm proteome.

In this study, the intra-assay variation for group 2 and 4 was 4.01% and 9.37%, respectively (Figure 2b). We have identified that only six proteins were differentially expressed between group 2 and 4 (Table 1). This indicates that the number of DEPs identified is very negligible (0.31%) compared with the total number of proteins identified in each group individually (Figure 2b). The majority of the proteins (AKAP3, CLPTM1, SLC25A15, and FAM210A) were underexpressed in group 4, while proteins SLC16A10 and COX6A1 were overexpressed (Table 1).

Functional annotation of the identified DEPs revealed that the proteins AKAP3 and COX6A1 are associated with sperm function. AKAP3 tyrosine phosphorylation levels regulates the degradation of AKAP3, which in turn is essential for the sperm capacitation process [28]. It is exclusively present in the principal piece of the flagellum of mature spermatozoa and is also expressed in elongated spermatids [29]. In the present study, AKAP3 was underexpressed in group 4 compared to group 2, suggesting the predominant existence of immature spermatozoa in semen samples with round cells and leukocytes > 1 × 106/mL. Mitochondrial protein COX6A1 plays a protective role during the excessive production of ROS [30]. Downregulation of COX6A1 in group 2 shows the presence of abnormal spermatozoa (with mitochondrial dysfunction) compared to group 4. Overall, the difference in the expression of proteins associated with sperm function, along with other proteins, are mainly due to the presence of abnormal spermatozoa in leukocytospermic samples. Therefore, despite the use of density gradient centrifugation to separate sperm population from non-sperm cells, the protein profile of normal spermatozoa from two different methods does not match exactly. This is mainly because of the presence of spermatozoa with varying maturation levels in the semen [31].

We also compared the sperm protein profile of frozen neat semen samples containing round cells and leukocytes ≥ 1 × 106/mL (group 1) with samples having round cells < 1 × 106/mL (group 3). A total of 26 proteins (1.18%) were differentially expressed between group 1 and 3 (Figure 2a). These DEPs were less than the intra-assay variability observed in group 1 (2.01%) and group 3 (1.74%). Bioinformatic analysis identified the top networks in which these DEPs were involved in cellular functions, such as (i) cell death and survival, cellular compromise, cellular function, and maintenance, and (ii) cellular assembly and organization, cell signaling, and molecular transport.

From the top networks, we noticed the overexpression of sperm specific proteins, such as ARSA, ALDH1A1, lactotransferrin (LTF), and calreticulin (CALR). ALDH1A1 is an indicator for impaired spermatogenesis or generation of abnormal sperm cells [32]. Overexpression of ALDH1 in group 1 suggest the higher abundance of spermatogenic round cells. Similarly, CALR protein is involved in the spermatogenic process and fertility potential [33]. Our proteomic analysis data show an overexpression of these proteins, which indicate the higher presence of abnormal spermatogenic round cells in group 1 relative to group 3. The protein ARSA is involved in fertilization and interacts with the heat shock 70 KDa protein 2 (HSPA2) and sperm adhesion molecule 1 (SPAM1), mediating sperm-egg interaction [34]. ARSA is also localized in acrosomal region of round and elongated spermatids [35]. In our study, the overexpression of ARSA in group 1 suggests higher presence of round spermatids and immature spermatozoa compared to group 3. Moreover, the protein LTF, localized with the eppin protein complex on the surface of spermatozoa [36], was overexpressed in group 1 (Table 2). It is abundantly expressed in seminal plasma samples with increased ROS levels [37]. Our LC-MS/MS results are in agreement with earlier reports suggesting that LTF is a sperm-specific protein. The identified networks suggest that these DEPs play an important role in spermatogenesis and maturation of spermatozoa, and alterations in their expression may compromise those mechanisms. This is substantiated by the presence of excessive round cells, including leukocytes in group 1, when compared with group 3. Expression of these proteins are either absent or very low in the control group (pure leukocyte culture) (Table 3). Thus, non-spermatogenic protein contribution to the whole sperm proteome is not significant.

Network analysis also revealed IZUMO1 as a focus molecule (Figure 2c), which was overexpressed in group 3. IZUMO1 is a membrane protein highly specific to spermatozoa and essential for spermatozoa fusion with the oocyte [38,39]. Likewise, isoform 4 of sodium/potassium-transporting ATPase subunit alpha-1 (ATP1A1) was also overexpressed in group 3 and it is essential for sperm capacitation [40,41]. Another overexpressed protein was the 26S proteasome non-ATPase regulatory subunit 3 (PSMD3), a component of ubiquitin-proteasome pathway, which along with proteasome machinery, regulates the exocytosis of the acrosome during fertilization [42,43]. The overexpression of IZUMO1, ATP1A1, and PSMD3 represents a sign of highly functional spermatozoa in group 3 relative to group 1. Therefore, the differential expression of proteins associated with sperm function between these groups is mainly due to the presence of abnormal sperm population in group 1 compared to group 3. Absence of IZUMO1 and PSMD3 proteins in leukocytes pure culture and significant expression of ATP1A1 in sperm samples (Table 3) indicates that the interference of non-spermatogenic proteins with sperm proteome is very negligible.

Apart from the DEPs associated with sperm function, the remaining DEPs observed in group 1 when compared with group 3 were either absent or significantly expressed in spermatozoa (Table 3). The functional pathways in which they are involved are of testicular or germ cell origin, and are not due to contamination of leukocytes or somatic cells. Therefore, the question of proteome contamination from other somatic round cells, including leukocytes, present in the semen is ruled out. Henceforth, the proteome of the samples containing round cells is rich in sperm proteins and proteins of non-spermatogenic origin were masked by sperm proteins. Thus, the purification of spermatozoa by density gradient is not essential for the accurate proteomic and bioinformatic analysis of sperm proteins.

This is the first study in the field of sperm proteomics that demonstrates the lack of interference of non-spermatogenic proteins in frozen semen samples. We validate the use of neat semen samples for sperm proteomic studies by LC-MS/MS. Further studies should examine the role of proteins in the immature germ cells (including spermatogenic round cells), aside from the known functions of proteins in mature and healthy sperm.

4. Materials and Methods 4.1. Semen Analysis

This study was approved by the Institutional Review Board of Cleveland Clinic (Cleveland, OH, USA). A total of 14 donors (normozoospermic; n = 14) enrolled in the study were provided with written consent. Semen samples were collected in a sterile container after a minimum of 48 h sexual abstinence. The samples were liquefied in an incubator at 37 °C for 30 mins. After complete liquefaction, macroscopic semen parameters, such as volume, color, pH, and viscosity, were measured. Viscosity of hyperviscous samples was broken down mechanically by repeated pipetting. The use of proteolytic enzymes was avoided for viscosity treatment as it interferes in proteomic analysis [44]. Microscopic semen parameters including sperm concentration, motility, and presence of round cells were determined according to World Health Organization (WHO) guidelines [25]. Additionally, Endtz test was conducted to measure leukocyte concentration (peroxidase positive cells) in semen samples when round cells ≥ 1 × 106/mL [7]. The semen specimens were first divided into (1) samples with round cells ≥1 × 106/mL and leukocytes ≥1 × 106/mL, and (2) samples with round cells < 1 × 106/mL.

4.2. Inclusion and Exclusion Criteria

Fertility status of the volunteers was not considered for including study subjects. Semen samples with more than 1.5 mL in volume were included, while samples with agglutination were excluded from the study.

4.3. Processing of Semen Samples

Each sample was divided into two equal aliquots. One of the aliquots was immediately stored as unprocessed (neat semen) at −80 °C. The other aliquot was processed by 65% single gradient centrifugation (Figure 3). Briefly, the liquefied neat semen was overlaid on the 65% gradient solution and centrifuged at 300× g for 20 min. The seminal plasma was removed and discarded. The white buffy coat ring (containing round cells, including leukocytes, and debris) formed between the seminal plasma and the gradient was also discarded. Furthermore, the gradient containing spermatozoa was diluted in phosphate buffered saline (PBS) and centrifuged at 3000× g for 15 min. The sperm pellet free from any round cells was stored at −80 °C.

4.4. Experimental Groups

Based on the concentration of round cells and leukocytes, and the sample processing, the experimental groups were defined as follows: Group 1 contained neat semen with round cells and leukocytes ≥ 1 × 106/mL; group 2 contained neat semen with round cells ≥ 1 × 106/mL that was processed by 65% density gradient (PureCeption, CooperSurgical Fertility and Genomic Solutions, Copenhagen, Denmark) to remove the round cells and leukocytes; group 3 contained neat semen with round cells < 1 × 106/mL; group 4 contained neat semen with round cells < 1 × 106/mL that was processed by 65% density gradient to remove the round cells. We have also included a human leukocyte pure culture (Innovative Research, Novi, MI, USA) as control group.

4.5. Preparation of Samples for Proteomic Analysis

Frozen samples were thawed at 37 °C and centrifuged at 3000× g for 10 min. Sperm pellet was resuspended and washed twice with PBS. The radio-immunoprecipitation assay (RIPA) lysis buffer (Sigma-Aldrich, St. Louis, MO, USA) supplemented with the proteinase inhibitor cocktail (Roche, Indianapolis, IN, USA) was added to the sperm pellet (approximately 100 µL/100 × 106 spermatozoa). Samples were incubated overnight at 4 °C for a complete cell lysis. Then, samples were centrifuged at 13000× g for 20 min, the supernatant was aspirated to a new vial, and protein concentration was determined using the bicinchoninic acid (BCA) kit (Thermo, Rockford, IL, USA), according to the manufacturer’s instructions. The same protocol was adapted for extraction of proteins from the leukocyte pellet.

4.6. Quantitative Proteomic Analysis

Five sperm samples from each experimental group (1, 2, 3, and 4) were subjected to proteomic analysis by LC-MS/MS for maintaining biological variability. The same amount of protein was used from each individual sample to normalize the total protein concentration in each group. Sperm samples (n = 5) were pooled to create each treatment. Pooling of samples for sperm proteomic analysis is a common practice and is reported in previous reports [22,37,45,46,47,48]. All the protein samples (~30 µg/sample) were run in triplicate (N1, N2, and N3) in 1D-PAGE to maintain technical variability. After completion of electrophoresis, each gel lane was cut into 6 pieces. The samples (cut pieces) were alkylated with iodoacetamine and reduced with dithiothreitol. In-gel digestion was carried out using 5 μL trypsin (10 ng/μL) and 50 mM ammonium bicarbonate, and incubated overnight at room temperature. Peptides from the digested gel were extracted using acetonitrile (50%) with formic acid (5%). Finally, samples were diluted with 1% acetic acid and used for LC-MS/MS analysis.

4.7. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Analysis

Firstly, samples (5 μL) of the peptide solutions were injected into high performance liquid chromatography (Dionex 15 cm × 75 μm, id Acclaim Pepmap C18, 2 μm, 100 Å reversed phase capillary chromatography) column. Fractions containing the peptides were eluted in acetonitrile/0.1% formic acid at a flow rate of 0.25 μL/min. Each peptide fraction was introduced into the source of Finnigan LTQ-Orbitrap Elite hybrid mass spectrometer on-line. The micro electrospray ion source was operated at 2.5 kV. Data dependent multitask ability of the instrument was used to complete a full spectral scan and to determine molecular weight and amino acid sequence of the peptides [37].

4.8. Database Searching

Proteome Discoverer version 1.4.1.288 was used to extract tandem mass spectra. Mascot (Matrix Science, London, UK; version 2.3.02), Sequest (XCorr Only) (Thermo Fisher Scientific, San Jose, CA, USA; version IseNode in Proteome Discoverer 2.2.0.388) and X! Tandem (The Global Proteome Machine (GPM), thegpm.org; version CYCLONE (2010.12.01.1)) were used in data searching process for all the samples. Mascot and X! Tandem were set up to search the human SwissProtKB database (July 2017 version, 42210 entries), assuming the digestion enzyme trypsin. Sequest (XCorr Only) was set up to search Human_SwissProt_July2017.fasta (42152 entries), also assuming trypsin. Carbamidomethyl of cysteine was specified as a fixed modification and oxidation of methionine was specified as a variable modification. Additional settings for data searches include fragment ion mass tolerance of 0.60 Da and a parent ion tolerance of 10.0 PPM. Results of a Mascot search were filtered using a threshold peptide ion score of 40 and at least two matching peptides. For the Sequest searches, the results were filtered based on the XCorr scores < 1.5 (+1 ions), > 2.0 (+2 ions), >2.5 (+3 ions). The false discovery rate (FDR) for these searches was determined to be less than 1%.

4.9. Criteria for Protein Identification

Identified peptides and proteins were validated using Scaffold (version Scaffold_4.8.6, Proteome Software Inc., Portland, OR, USA). With the help of Scaffold delta-mass correction, peptide identifications were accepted if they could be established at greater than 95.0% probability by the Peptide Prophet algorithm [49]. For proteins, the probability had to be >90% to achieve an FDR less than 1% and contained at least 2 identified peptides. Protein probabilities were assigned by the Protein Prophet algorithm [50]. Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony.

4.10. Comparative Proteomics and Identification of Differentially Expressed Proteins

The proteomic profile of all groups were analyzed. Coefficient of variation was used to measure intra assay variability (between the technical replicates) for group 1, 2, 3, and 4. Comparative analysis of the DEPs were performed between group 1 and group 3; and group 2 and group 4. Statistical significance of proteomic results was assessed by independent t-test. Different p-values were considered according to the abundance of the proteins: (i) Very Low abundance: spectral count range 1.7–7, p ≤ 0.001, and NSAF ratio ≥ 2.5 for overexpressed, ≤0.4 for underexpressed proteins; (ii) low abundance: spectral count range 8–19, p ≤ 0.01, and NSAF ratio ≥ 2.5 for overexpressed, ≤0.4 for underexpressed proteins; (iii) medium abundance: spectral count range between 20 and 79, p ≤ 0.05, and NSAF ratio ≥ 2.0 for overexpressed, ≤0.5 for underexpressed proteins; (iv) high abundance: spectral counts > 80, p ≤ 0.05, and NSAF ratio ≥ 1.5 for overexpressed, ≤ 0.67 for underexpressed proteins.

4.11. Bioinformatic Analysis of DEPs

Annotation of proteins was performed using Gene Ontology (GO) terms from National Center for Biotechnology Information (NCBI). Also, protein IDs and symbols were extracted from uniport database. DEPs identified in both study groups were subjected to functional annotation and enrichment analysis using publicly available bioinformatic annotation tools and databases, such as Universal Protein Resource (UniProt), Reactome and Database for Annotation Visualization and Integrated Discovery (DAVID) (http://david.niaid.nih.gov), and proprietary curated database Ingenuity pathway analysis (IPA) to analyze the involvement of DEPs in biological and cellular processes, pathways, regulatory networks, and protein-protein interactions.

Figure 1. Comparative proteomic analysis of semen samples with round cells and leukocytes ≥1 × 106/mL or round cells <1 × 106/mL. (a) Total number of proteins detected in group 1 and group 3 run in triplicate (N1, N2, and N3), and differentially expressed proteins in group 1 vs. group 3; and (b) total number of proteins detected in group 2 and group 4 run in triplicate (N1, N2, and N3), and differentially expressed proteins in group 2 vs. group 4. Group 1 contained neat semen with round cells and leukocytes ≥ 1 × 106/mL, group 2 contained neat semen with round cells ≥ 1 × 106/mL that was processed by 65% density gradient to remove the round cells and leukocytes, group 3 contained neat semen with round cells <1 × 106/mL, and group 4 contained neat semen with round cells <1 × 106/mL that was processed by 65% density gradient to remove the round cells. CV: coefficient of variation, DEPs: differentially expressed proteins, OE: overexpressed, UE: underexpressed.

Figure 2. Top networks associated with differentially expressed proteins in group 1 vs. group 3. (a) Cell death and survival, cellular compromise, cellular function, and maintenance; (b) cellular assembly and organization, cell signaling, molecular transport; and (c) cellular assembly and organization, embryonic development, organismal development. Group 1: neat semen samples with round cells and leukocytes ≥ 1 × 106/mL. Group 3: neat semen samples with round cells <1 × 106/mL.

Figure 3. Schematic flowchart of overall experimental design. Normozoospermic samples were divided into four groups. Proteomic profile of sperm was evaluated by LC-MS/MS and compared with a pure leukocyte culture.

Uniprot No. Gene Name Protein Name Group 1 Group 3 NSAF Ratio Expression
SC Abun SC Abun
P15289ARSAArylsulfatase A34.0M1.7VL0.05UE
P00352ALDH1A1Retinal dehydrogenase 126.3M2.7VL0.09UE
Q6PEW0PRSS54Inactive serine protease 5418.0L4.7VL0.22UE
Q76KD6SPATC1Speriolin8.3L2.3VL0.26UE
Q9HAE3EFCAB1EF-hand calcium-binding domain-containing protein 19.3L3.3VL0.33UE
O43707ACTN4Alpha-actinin-444.7M23.3L0.47UE
P02788LTFLactotransferrin2486.7H1299.0H0.47UE
P14314PRKCSHGlucosidase 2 subunit beta123.0H65.0M0.48UE
P27797CALRCalreticulin271.7H175.0H0.57UE
P14625HSP90B1Endoplasmin987.0H660.3H0.60UE
P05023-4ATP1A1Isoform 4 of Sodium/potassium-transporting ATPase subunit alpha-198.7H181.3H1.61OE
O95202LETM1Mitochondrial proton/calcium exchanger protein29.0M65.7M2.04OE
O43242PSMD326S proteasome non-ATPase regulatory subunit 333.7M78.3M2.04OE
P23396RPS340S ribosomal protein S324.7M60.0M2.20OE
P11234RALBRas-related protein Ral-B9.0L22.0M2.25OE
Q9NZM1-3MYOFIsoform 3 of Myoferlin21.3M55.3M2.27OE
Q9Y4W6AFG3L2AFG3-like protein 215.3L40.7M2.38OE
Q96RQ1ERGIC2Endoplasmic reticulum-Golgi intermediate compartment protein 28.3L23.0M2.52OE
Q8IYV9IZUMO1Izumo sperm-egg fusion protein 19.0L28.7M3.00OE
Q04609FOLH1Glutamate carboxypeptidase 227.0M96.3H3.21OE
Q8IY17-4PNPLA6Isoform 4 of Neuropathy target esterase3.7VL14.0L3.36OE
P62277RPS1340S ribosomal protein S135.3VL20.7M3.42OE
P46777RPL560S ribosomal protein L55.7VL24.7M3.93OE
Q13093PLA2G7Platelet-activating factor acetylhydrolase5.3VL22.7M4.02OE
O43653PSCAProstate stem cell antigen1.7VL14.3L7.22OE
Q96M98-2PACRGIsoform 2 of Parkin coregulated gene protein1.3VL21.0M13.04OE

VL: very low; L: low; M: medium; H: high; UE: underexpressed; OE: overexpressed; NSAF: normalized spectral abundance factor; Abun: abundance; SC: spectral count.

Uniprot No. Gene Name Protein Name Group 2 Group 4 NSAF Ratio Expression
SC Abun SC Abun
O75969AKAP3A-kinase anchor protein 3146.3H81.7H0.56UE
O96005CLPTM1Cleft lip and palate transmembrane protein 141.3M19.0L0.45UE
Q9Y619SLC25A15Mitochondrial ornithine transporter 126.0M12.0L0.47UE
Q8TF71SLC16A10Monocarboxylate transporter 102.0VL0.0-0.00Unique to Group 2
Q96ND0FAM210AProtein FAM210A5.0VL0.7VL0.14OE
P12074COX6A1Cytochrome c oxidase subunit 6A1, mitochondrial10.0L21.0M2.15OE

VL: very low; L: low; M: medium; H: high; UE: underexpressed; OE: overexpressed; NSAF: normalized spectral abundance factor; Abun: abundance; SC: spectral count.

Uniprot No. Gene Name Protein Name Group 1 Group 3 Control Group (CG) NSAF Ratio

CG/ Group1

Expression

in CG

SC Abun SC Abun SC Abun
P00352ALDH1A1Retinal dehydrogenase 126.3M2.7VL0.0-0.00Absent in CG
Q6PEW0PRSS54Inactive serine protease 5418.0L4.7VL0.0-0.00Absent in CG
Q76KD6SPATC1Speriolin8.3L2.3VL0.0-0.00Absent in CG
Q9HAE3EFCAB1EF-hand calcium-binding domain-containing protein 19.3L3.3VL0.0-0.00Absent in CG
O43242PSMD326S proteasome non-ATPase regulatory subunit 333.7M78.3M0.0-0.00Absent in CG
P23396RPS340S ribosomal protein S324.7M60.0M0.0-0.00Absent in CG
Q9NZM1-3MYOFIsoform 3 of Myoferlin21.3M55.3M0.0-0.00Absent in CG
Q96RQ1ERGIC2Endoplasmic reticulum-Golgi intermediate compartment protein 28.3L23.0M0.0-0.00Absent in CG
Q8IYV9IZUMO1Izumo sperm-egg fusion protein 19.0L28.7M0.0-0.00Absent in CG
Q04609FOLH1Glutamate carboxypeptidase 227.0M96.3H0.0-0.00Absent in CG
Q8IY17-4PNPLA6Isoform 4 of Neuropathy target esterase3.7VL14.0L0.0-0.00Absent in CG
P62277RPS1340S ribosomal protein S135.3VL20.7M0.0-0.00Absent in CG
Q13093PLA2G7Platelet-activating factor acetylhydrolase5.3VL22.7M0.0-0.00Absent in CG
O43653PSCAProstate stem cell antigen1.7VL14.3L0.0-0.00Absent in CG
Q96M98-2PACRGIsoform 2 of Parkin coregulated gene protein1.3VL21.0M0.0-0.00Absent in CG
P46777RPL560S ribosomal protein L55.7VL24.7M1.3M0.36UE
P15289ARSAArylsulfatase A34.0M1.7VL4.7VL0.20UE
P02788LTFLactotransferrin2486.7H1299.0H424.3H0.24UE
P14314PRKCSHGlucosidase 2 subunit beta123.0H65.0M33.7M0.39UE
P27797CALRCalreticulin271.7H175.0H123.0H0.65UE
P14625HSP90B1Endoplasmin987.0H660.3H73.3M0.11UE
P05023-4ATP1A1Isoform 4 of Sodium/potassium-transporting ATPase subunit alpha-198.7H181.3H27.3M0.39UE
O95202LETM1Mitochondrial proton/calcium exchanger protein29.0M65.7M9.0L0.46UE
Q9Y4W6AFG3L2AFG3-like protein 215.3L40.7M0.7VL0.06UE
P11234RALBRas-related protein Ral-B9.0L22.0M62.0M10.12OE
O43707ACTN4Alpha-actinin-444.7M23.3L52.3M1.73OE

Expression VL: very low; L: low; M: medium; H: high; UE: underexpressed; OE: overexpressed; NSAF: normalized spectral abundance factor; Abun: abundance; SC: spectral count; CG: control group.

Supplementary Materials

Supplementary materials can be found at https://www.mdpi.com/1422-0067/20/2/314/s1.

Author Contributions

Project administration and study design, A.A.; methodology, data curation, software, writing-original draft preparation, review and editing, M.K.P.S.; writing-review and editing, T.R.D., L.S., A.D.M., A.A. All authors read and approved the final manuscript.

Funding

Financial support for this study was provided by the American Center for Reproductive Medicine, Cleveland Clinic, Ohio, USA.

Acknowledgments

Belinda Willard, Director of Proteomic Core Laboratory, Lerner Research Institute assisted with proteomic analysis. The Orbitrap Elite instrument was purchased via an NIH shared instrument grant, 1S10RR031537-01. Research support for this study was provided by the American Center for Reproductive Medicine.

Conflicts of Interest

The authors declare no conflict of interest.

© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

1. Ganong, W.F.; Ganong, W. Review of Medical Physiology; Appleton & Lange: Norwalk, CT, USA, 1995.

2. Samanta, L.; Parida, R.; Dias, T.R.; Agarwal, A. The enigmatic seminal plasma: A proteomics insight from ejaculation to fertilization. Reprod. Biol. Endocrinol. 2018, 16.

3. Johanisson, E.; Campana, A.; Luthi, R.; De Agostini, A. Evaluation ofround cells' in semen analysis: A comparative study. Hum. Reprod. Update 2000, 6, 404-412.

4. Palermo, G.D.; Neri, Q.V.; Cozzubbo, T.; Cheung, S.; Pereira, N.; Rosenwaks, Z. Shedding Light on the Nature of Seminal Round Cells. PLOS ONE 2016, 11, e0151640.

5. De Bellabarba, G.A.; Tortolero, I.; Villarroel, V.; Molina, C.Z.; Bellabarba, C.; Velazquez, E. Nonsperm cells in human semen and their relationship with semen parameters. Arch. Androl. 2000, 45, 131-136.

6. Majzoub, A.; Esteves, S.C.; Gosálvez, J.; Agarwal, A. Specialized sperm function tests in varicocele and the future of andrology laboratory. Asian J. Androl. 2016, 18, 205-212.

7. Agarwal, A.; Gupta, S.; Sharma, R. Leukocytospermia Quantitation (ENDTZ) Test. In Andrological Evaluation of Male Infertility: A Laboratory Guide; Agarwal, A., Gupta, S., Sharma, R., Eds.; Springer International Publishing: Cham, Switzerland, 2016; pp. 69-72.

8. Shafer, M.-A.; Beck, A.; Blain, B.; Dole, P.; Irwin, C.E.; Sweet, R.; Schachter, J. Chlamydia trachomatis: Important relationships to race, contraception, lower genital tract infection, and Papanicolaou smear. J. Pediatr. 1984, 104, 141-146.

9. Saleh, R.A.; Agarwal, A.; Sharma, R.K.; Nelson, D.R.; Thomas, A.J., Jr. Effect of cigarette smoking on levels of seminal oxidative stress in infertile men: A prospective study. Fertil. Steril. 2002, 78, 491-499.

10. Maneesh, M.; Dutta, S.; Chakrabarti, A.; Vasudevan, D. Alcohol abuse-duration dependent decrease in plasma testosterone and antioxidants in males. Indian J. Physiol. Pharmacol. 2006, 50, 291-296.

11. Agarwal, A.; Mulgund, A.; Alshahrani, S.; Assidi, M.; Abuzenadah, A.M.; Sharma, R.; Sabanegh, E. Reactive oxygen species and sperm DNA damage in infertile men presenting with low level leukocytospermia. Reprod. Biol. Endocrinol. 2014, 12.

12. Henkel, R.R.; Schill, W.B. Sperm preparation for ART. Reprod. Biol. Endocrinol. 2003, 1, 108.

13. Beydola, T.; Sharma, R.K.; Lee, W.; Agarwal, A. Sperm preparation and selection techniques. Male Infertil. Pract. 2013, 29, 244-251.

14. Allamaneni, S.S.; Agarwal, A.; Rama, S.; Ranganathan, P.; Sharma, R.K. Comparative study on density gradients and swim-up preparation techniques utilizing neat and cryopreserved spermatozoa. Asian J. Androl. 2005, 7, 86-92.

15. Panner Selvam, M.K.; Agarwal, A. Update on the proteomics of male infertility: A systematic review. Arab J. Urol. 2018, 16, 103-112.

16. Amaral, A.; Castillo, J.; Ramalho-Santos, J.; Oliva, R. The combined human sperm proteome: Cellular pathways and implications for basic and clinical science. Hum. Reprod. Update 2014, 20, 40-62.

17. Wang, S.; Wang, W.; Xu, Y.; Tang, M.; Fang, J.; Sun, H.; Sun, Y.; Gu, M.; Liu, Z.; Zhang, Z. Proteomic characteristics of human sperm cryopreservation. Proteomics 2014, 14, 298-310.

18. Amaral, A.; Paiva, C.; Attardo Parrinello, C.; Estanyol, J.M.; Ballescà, J.L.; Ramalho-Santos, J.; Oliva, R. Identification of proteins involved in human sperm motility using high-throughput differential proteomics. J. Proteome Res. 2014, 13, 5670-5684.

19. Martínez-Heredia, J.; Estanyol, J.M.; Ballescà, J.L.; Oliva, R. Proteomic identification of human sperm proteins. Proteomics 2006, 6, 4356-4369. [Green Version]

20. Wang, X.M.; Xiang, Z.; Fu, Y.; Wu, H.L.; Zhu, W.B.; Fan, L.Q. Comparative Proteomics Reveal the Association between SPANX Proteins and Clinical Outcomes of Artificial Insemination with Donor Sperm. Sci. Rep. 2018, 8, 6850.

21. Intasqui, P.; Camargo, M.; Del Giudice, P.T.; Spaine, D.M.; Carvalho, V.M.; Cardozo, K.H.M.; Cedenho, A.P.; Bertolla, R.P. Unraveling the sperm proteome and post-genomic pathways associated with sperm nuclear DNA fragmentation. J. Assist. Reprod. Genet. 2013, 30, 1187-1202. [Green Version]

22. Bogle, O.; Kumar, K.; Attardo-Parrinello, C.; Lewis, S.; Estanyol, J.; Ballescà, J.; Oliva, R. Identification of protein changes in human spermatozoa throughout the cryopreservation process. Andrology 2017, 5, 10-22.

23. Intasqui, P.; Agarwal, A.; Sharma, R.; Samanta, L.; Bertolla, R. Towards the identification of reliable sperm biomarkers for male infertility: A sperm proteomic approach. Andrologia 2018, 50, e12919.

24. Samanta, L.; Agarwal, A.; Swain, N.; Sharma, R.; Gopalan, B.; Esteves, S.C.; Durairajanayagam, D.; Sabanegh, E. Proteomic Signatures of Sperm Mitochondria in Varicocele: Clinical Utility as Biomarkers of Varicocele Associated Infertility. J. Urol. 2018, 200, 414-422.

25. WHO. WHO Laboratory Manual for the Examination and Processing of Human Semen, 5th ed.; World Health Organization: Geneva, Switzerland, 2010.

26. Dad, B.R.; Li-Jun, H. Posttranslational Modifications in Spermatozoa and Effects on Male Fertility and Sperm Viability. Omics J. Integr. Biol. 2017, 21, 245-256.

27. Samanta, L.; Swain, N.; Ayaz, A.; Venugopal, V.; Agarwal, A. Post-Translational Modifications in sperm Proteome: The Chemistry of Proteome diversifications in the Pathophysiology of male factor infertility. Biochim. Biophys. Acta Gen. Subj. 2016, 1860, 1450-1465.

28. Vizel, R.; Hillman, P.; Ickowicz, D.; Breitbart, H. AKAP3 degradation in sperm capacitation is regulated by its tyrosine phosphorylation. Biochim. Biophys. Acta Gen. Subj. 2015, 1850, 1912-1920.

29. Xu, K.; Qi, H. Sperm-specific AKAP3 is a dual-specificity anchoring protein that interacts with both protein kinase a regulatory subunits via conserved N-terminal amphipathic peptides. Mol. Reprod. Dev. 2014, 81, 595-607.

30. Rahman, M.S.; Kwon, W.S.; Yoon, S.J.; Park, Y.J.; Ryu, B.Y.; Pang, M.G. A novel approach to assessing bisphenol-A hazards using an in vitro model system. BMC Genom. 2016, 17.

31. Cui, Z.; Sharma, R.; Agarwal, A. Proteomic analysis of mature and immature ejaculated spermatozoa from fertile men. Asian J. Androl. 2016, 18, 735-746.

32. Raverdeau, M.; Gely-Pernot, A.; Féret, B.; Dennefeld, C.; Benoit, G.; Davidson, I.; Chambon, P.; Mark, M.; Ghyselinck, N.B. Retinoic acid induces Sertoli cell paracrine signals for spermatogonia differentiation but cell autonomously drives spermatocyte meiosis. Proc. Natl. Acad. Sci. USA 2012, 109, 16582-16587. [Green Version]

33. Ikawa, M.; Tokuhiro, K.; Yamaguchi, R.; Benham, A.M.; Tamura, T.; Wada, I.; Satouh, Y.; Inoue, N.; Okabe, M. Calsperin is a testis-specific chaperone required for sperm fertility. J. Biol. Chem. 2011, 286, 5639-5646.

34. Redgrove, K.A.; Nixon, B.; Baker, M.A.; Hetherington, L.; Baker, G.; Liu, D.-Y.; Aitken, R.J. The Molecular Chaperone HSPA2 Plays a Key Role in Regulating the Expression of Sperm Surface Receptors That Mediate Sperm-Egg Recognition. PLoS ONE 2012, 7, e50851.

35. Weerachatyanukul, W.; Xu, H.; Anupriwan, A.; Carmona, E.; Wade, M.; Hermo, L.; da Silva, S.M.; Rippstein, P.; Sobhon, P.; Sretarugsa, P.; et al. Acquisition of Arylsulfatase A onto the Mouse Sperm Surface During Epididymal Transit1. Biol. Reprod. 2003, 69, 1183-1192.

36. Wang, Z.; Widgren, E.E.; Richardson, R.T.; O'Rand, M.G. Characterization of an Eppin Protein Complex from Human Semen and Spermatozoa1. Biol. Reprod. 2007, 77, 476-484. [Green Version]

37. Sharma, R.; Agarwal, A.; Mohanty, G.; Du Plessis, S.S.; Gopalan, B.; Willard, B.; Yadav, S.P.; Sabanegh, E. Proteomic analysis of seminal fluid from men exhibiting oxidative stress. Reprod. Biol. Endocrinol. 2013, 11, 85. [Green Version]

38. Inoue, N.; Hamada, D.; Kamikubo, H.; Hirata, K.; Kataoka, M.; Yamamoto, M.; Ikawa, M.; Okabe, M.; Hagihara, Y. Molecular dissection of IZUMO1, a sperm protein essential for sperm-egg fusion. Development 2013, 140, 3221-3229. [Green Version]

39. Ohto, U.; Ishida, H.; Krayukhina, E.; Uchiyama, S.; Inoue, N.; Shimizu, T. Structure of IZUMO1-JUNO reveals sperm-oocyte recognition during mammalian fertilization. Nature 2016, 534, 566.

40. Newton, L.D. Na(+)/K(+)ATPase Regulates Sperm Capacitation Through a Mechanism Involving Kinases and Redistribution of Its Testis-Specific Isoform. Mol. Reprod. Dev. 2010, 77, 136-148.

41. Rajamanickam, G.D.; Kastelic, J.P.; Thundathil, J.C. Na/K-ATPase regulates bovine sperm capacitation through raft- and non-raft-mediated signaling mechanisms. Mol. Reprod. Dev. 2017, 84, 1168-1182.

42. Sutovsky, P. Sperm proteasome and fertilization. Reproduction 2011, 142, 1-14. [Green Version]

43. Morales, P.; Kong, M.; Pizarro, E.; Pasten, C. Participation of the sperm proteasome in human fertilization. Hum. Reprod. 2003, 18, 1010-1017. [Green Version]

44. Panner Selvam, M.; Agarwal, A.; Sharma, R.; Samanta, L. Treatment of semen samples with α-chymotrypsin alters the expression pattern of sperm functional proteins-A pilot study. Andrology 2018, 6, 345-350.

45. Agarwal, A.; Ayaz, A.; Samanta, L.; Sharma, R.; Assidi, M.; Abuzenadah, A.M.; Sabanegh, E. Comparative proteomic network signatures in seminal plasma of infertile men as a function of reactive oxygen species. Clin. Proteom. 2015, 12, 23.

46. Ayaz, A.; Agarwal, A.; Sharma, R.; Arafa, M.; Elbardisi, H.; Cui, Z. Impact of precise modulation of reactive oxygen species levels on spermatozoa proteins in infertile men. Clin. Proteom. 2015, 12, 4. [Green Version]

47. Sharma, R.; Agarwal, A.; Mohanty, G.; Jesudasan, R.; Gopalan, B.; Willard, B.; Yadav, S.P.; Sabanegh, E. Functional proteomic analysis of seminal plasma proteins in men with various semen parameters. Reprod. Biol. Endocrinol. 2013, 11, 38. [Green Version]

48. Diz, A.P.; Truebano, M.; Skibinski, D.O. The consequences of sample pooling in proteomics: An empirical study. Electrophoresis 2009, 30, 2967-2975.

49. Keller, A.; Nesvizhskii, A.I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.

50. Nesvizhskii, A.I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.

1American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH 44195, USA

2Universidade da Beira Interior, 6201-001 Covilhã, Portugal

3Department of Microscopy, Laboratory of Cell Biology, Institute of Biomedical Sciences Abel Salazar and Unit for Multidisciplinary Research in Biomedicine, University of Porto, 4050-313 Porto, Portugal

4Redox Biology Laboratory, Department of Zoology, School of Life Sciences, Ravenshaw University, Cuttack 753003, India

*Author to whom correspondence should be addressed.

Word count: 5857

Show less

© 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

[...]the extracted total protein will contain a mixture of both sperm and round cell proteins [16]. To date, some studies have used only pure cultures of sperm (without round cells) for global proteomic analysis [17,18,19,20,21], whereas others have used neat semen samples [20,22,23,24]. [...]it is still unclear (1) whether the processing of semen samples have any interference in the sperm protein expression, and (2) what the contribution is of non-spermatogenic proteins in the evaluation of sperm proteomic profile. Transcriptionally and translationally silent spermatozoa depend on the proteins and their post-translational modifications in order to carry out their normal physiological functions to ultimately fertilize the oocyte [26,27]. [...]accurate identification and quantification of proteins in mature and immature spermatozoa provides insight into the function of each protein. Overall, the difference in the expression of proteins associated with sperm function, along with other proteins, are mainly due to the presence of abnormal spermatozoa in leukocytospermic samples. [...]despite the use of density gradient centrifugation to separate sperm population from non-sperm cells, the protein profile of normal spermatozoa from two different methods does not match exactly.

Details

Title
Presence of Round Cells Proteins do not Interfere with Identification of Human Sperm Proteins from Frozen Semen Samples by LC-MS/MS
Author
Manesh Kumar Panner Selvam; Agarwal, Ashok; Dias, Tânia R; Martins, Ana D; Luna Samanta
Publication year
2019
Publication date
2019
Publisher
MDPI AG
ISSN
16616596
e-ISSN
14220067
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.3390/ijms20020314
ProQuest document ID
2331905912
Copyright
© 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.